Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation
Benjamin Brenner, Charles W. Francis*, Saara Totterman, Craig M. Kessler, A. Koneti Rao, Ronald Rubin, Hau C. Kwaan, K. Ruben Gabriel, Victor J. Marder
Dive into the research topics of 'Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation'. Together they form a unique fingerprint.